Covid: MapmyGenome, Apollo Clinic Offer DNA-Based Tests
Originally published in Financial Express, June 27, 2020
MapmyGenome, a genomics company offering personalised health solutions based on genetic tests, has joined hands with Apollo Clinic to offer DNA-based tests that give risk and immunity reports. These tests include screening for health & wellness and ancestry testing during the Covid-19 pandemic — for understanding genetic predispositions of people to know why some people suffer more than others, understand how the virus mutates, and come up with new drug targets.
“Researchers across the globe have been studying the viral genome to understand its mechanism of action and to find possible ways to stop the spread. Genomics has proven to be a valuable tool in COVID diagnostics and testing,” says Anu Acharya, CEO, MapmyGenome.
MapmyGenome’s Genomepatri or ‘health horoscope’ is a master health test with 100-odd reports on lifestyle disease, physiological traits, drug response, and carrier status. A flagship product from MapmyGenome, it is the most comprehensive genetic assessment available for preventive screening. Genomepatri and Genomepatri Lite include genetic risk assessment of health risks which affect COVID severity and immunity.
India’s #1 Personal Genomics Company
Genomepatri by MapmyGenome — India’s most comprehensive at-home DNA wellness test, covering 100+ health conditions, nutrition, fitness, and drug response traits. Backed by certified genetic counsellors and a CAP & NABL-accredited laboratory.
